Published online Feb 15, 2022. doi: 10.4239/wjd.v13.i2.110
Peer-review started: August 23, 2021
First decision: December 4, 2021
Revised: December 10, 2021
Accepted: January 6, 2022
Article in press: January 6, 2022
Published online: February 15, 2022
Processing time: 169 Days and 19.2 Hours
Whole-brain functional connectivity patterns, or large-scale functional connectivity (LSFC) patterns, are both highly unique and reliable in each individual, and similar to a fingerprint, can identify individual differences in personality traits or cognitive functions. Abnormal LSFC patterns have been found in patients with dementia, as well as in those with mild cognitive impairment (MCI), which predicted their cognitive performance. It has been reported that patients with type 2 diabetes mellitus (T2DM) may develop MCI that could progress to dementia. We assessed the applicability of LSFC-related discriminative features to predict the cognitive level of patients with T2DM using a connectome-based predictive modeling (CPM) and support vector machine (SVM).
Whether machine learning techniques like CPM and SVM could utilize LSFC patterns to predict T2DM-related MCI with a high degree of accuracy remains unclear.
To investigate the utility of LSFC for more accurately and reliably predicting the cognitive impairment related to T2DM.
Resting-state functional magnetic resonance images were derived from 42 patients with T2DM and 24 healthy controls. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA). Patients with T2DM were divided into two groups, according to the presence (T2DM-C; n = 16) or absence (T2DM-NC; n = 26) of MCI. Brain regions were marked using the Harvard Oxford (HOA-112), automated anatomical labeling (AAL-116), and 264-region functional (Power-264) atlases. LSFC biomarkers for predicting MoCA scores were identified using a new CPM technique. Subsequently, we used the SVM based on LSFC patterns for among-group differentiation. The area under the receiver operating characteristic curve determined the classification appearance.
CPM could predict MoCA scores in patients with T2DM, indicating that LSFC patterns represent cognition-level measures in these patients. Positive (anti-correlated) LSFC networks based on the Power-264 atlas showed the best predictive performance (r=0.42, P=0.0038); moreover, we observed new brain regions of interest associated with T2DM-related cognition. The area under the receiver operating characteristic curve values (T2DM-NC group vs. T2DM-C group) were 0.65-0.70, with LSFC matrices based on HOA-112 and Power-264 atlases having the highest value (0.70). Most discriminative and attractive LSFCs were related to the default mode network, limbic system, and basal ganglia.
LSFC provides neuroimaging-based information that may be useful in detecting MCI early and accurately in patients with T2DM and therefore assist with T2DM management.
Our study provides promising evidence that LSFC can reveal cognitive impairment in patients with T2DM, although further development is needed for clinical application.